Collaborative Fund Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$576K Buy
+3,863
New +$542K 0.31% 91
2026
Q2
– Sell
-6,930
Closed -$966K – 211
2026
Q1
$966K Buy
+6,930
New +$970K 0.6% 60

Other funds holding GILD

Collaborative Fund Advisors's GILD Position: Q3 2026 in Review

Collaborative Fund Advisors opened a new position in Gilead Sciences (GILD) in Q3 2026: 3,863 shares worth $576K. The stake represents 0.31% of the portfolio and ranks #91 among its holdings. This is a return to the name: Collaborative Fund Advisors previously reported a position in GILD as recently as Q1 2026.

Collaborative Fund Advisors first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $966K in Q1 2026. 2,342 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Collaborative Fund Advisors held 3,863 shares of Gilead Sciences worth $576K as of Q3 2026.
  • Gilead Sciences was a new Collaborative Fund Advisors position in Q3 2026.
  • Gilead Sciences made up 0.31% of Collaborative Fund Advisors's portfolio in Q3 2026, its #91 holding.
  • Collaborative Fund Advisors first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Collaborative Fund Advisors's Gilead Sciences position peaked at $966K in Q1 2026.
  • 2,342 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.